Abzena

Abzena launches AbZelect platforms for improving cell line development efficiency on the pathway to IND

16 January 2023 – San Diego, CA, US — Abzena, the leading end-to-end CDMO for biologics and bioconjugates, has launched AbZelect and AbZelectPRO cell line development (CLD) platforms for accelerating the generation of production cell lines for manufacture of antibodies and recombinant proteins. The platforms will enable Abzena to rapidly progress their customer’s complex biologic...

Abzena launches AbZelect platforms for improving cell line development efficiency on the pathway to IND

16 January 2023 -- California, US -- Abzena, the leading end-to-end CDMO for biologics and bioconjugates, has launched AbZelect and AbZelectPRO cell line development (CLD) platforms for accelerating the generation of production cell lines for manufacture of antibodies and recombinant proteins. The platforms will enable Abzena to rapidly progress their customer’s complex biologic drug programmes...
Babraham Research Campus, Cambridge, CB22 3AT United Kingdom

+44 1223 903498